AeroEclipse® II BAN Nebulizers

Manufacturer: MONAGHAN MEDICAL CORPORATION
Manufacturer: MONAGHAN MEDICAL CORPORATION

The AeroEclipse® II  Breath Actuated Nebulizer (BAN) creates aerosol in response to the patient's inspiratory flow.  This patient on-demand therapy means less medication waste, higher drug delivery efficiency and safer clinician working environments.

Combining the benefits of breath actuation and a superior aerosol particle size, the AeroEclipse® II BAN delivers the industry’s most effective respirable dose. Supported by clinical evidence, the AeroEclipse® II BAN provides approved dosing protocols throughout the hospital and for all patient populations. 

  • Breath actuated technology
  • Consistent respirable dose
  • Virtually no drug is lost to the environment
  • Protection from second-hand aerosols
  • Minimizes medication waste 
  • Efficient treatment times
  • Biofeedback button confirms actuation and inhalation 
  • Reduced Length of Stay and Admission Rates through the ER1
  • Not Made or Manufactured with BPA, Natural Rubber Latex, Phthalates, Lead, or PVC 
  • Designed and manufactured in North America
You are unable to select more than your available quota at this time. Please contact your administrator for assistance.